Xaira wins the 2026 Fierce AI Innovation Award for Preclinical Development!

Xaira wins the 2026 Fierce AI Innovation Award for Preclinical Development!

The award recognizes X-Atlas/Pisces and X-Cell, the foundational technologies at the heart of Xaira’s approach to drug discovery. By generating biological data at unprecedented scale, building models that learn from that data, and leveraging those advances for therapeutic development, we’re working to better understand biology and accelerate the discovery of new medicines.

Read the story

Our ApproachOur TeamWork With UsNews & Content

A New Era
in Medicine

We are pioneering the transformative artificial intelligence that will help discover and develop the next generation of life-changing medicines.

AI will transform drug discovery by enabling us to make predictions about the right biology to target, the best therapeutic to modulate those targets, and the patients and disease states that will benefit most from those medicines.

We are building predictive and agentic AI models across the complete spectrum of the drug discovery and development process to deliver a pipeline of next generation medicines. We believe the industry must migrate to an engineered approach to delivering therapies to patients that will increase the probability of success, reduce development timelines, and lower costs.

See How

Contact Us
Xaira Therapeutics, Inc.
700 Gateway Blvd, 4th Floor
South San Francisco, CA 94080
©2024 Xaira Therapeutics
Privacy PolicyCookie PolicyTerms & Conditions

Announcing our first blog post, titled "Progressable Binders: The Binders that Matter"

Read the story